Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

A Topical Drug Formulation To Relieve Osteoarthritis Pain and Inflammation

FY 2024-25

Summary
Current approaches to Osteoarthritis (OA) pain management are frequently ineffective or causeconsiderable side effects for the patient. Millions of people worldwide suffer from OA, and alack of adequate care contributes to a decreased quality of life and high healthcare costs. Thispresents a clear need for effective localized treatments that manage OA pain without significantside effects. A novel opioid, KK-103 targets pain directly at the source without the side effects oftraditional opioids. Our research aims to develop a topical cream with enhanced skin absorption,allowing KK-103 to reach affected joints and provide targeted pain relieve. First, the safety oftwo skin permeation enhancers, dimethyl sulfoxide (DMSO) and dimerized protamine (P2), will be determined. A range of formulations will then be tested in a laboratory model to measure theabsorption of KK-103 through the skin. Promising formulations will be further tested in a ratmodel of OA to assess their pain-relieving and anti-inflammatory effects. This project isexpected to yield a topical cream that will effectively relieve OA pain with minimal side effects.Combining KK-103 with advanced permeation techniques is a new approach that couldrevolutionize OA pain management. This localized treatment has the potential to provide a safer,more effective option for patients, contributing to an improved quality of life and reducedreliance on systemic drugs.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529920
Name
Oke Benjamin T
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A Topical Drug Formulation To Relieve Osteoarthritis Pain and Inflammation
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Analgesic; Anti-Inflammatory; Delta Opioid Receptors; Drug Delivery; Inflammation; Leucine-Enkephalin; Osteoarthritis; Pain Management; Skin Permeation Enhancers; Topical Formulation
Abstract
Current approaches to Osteoarthritis (OA) pain management are frequently ineffective or causeconsiderable side effects for the patient. Millions of people worldwide suffer from OA, and alack of adequate care contributes to a decreased quality of life and high healthcare costs. Thispresents a clear need for effective localized treatments that manage OA pain without significantside effects. A novel opioid, KK-103 targets pain directly at the source without the side effects oftraditional opioids. Our research aims to develop a topical cream with enhanced skin absorption,allowing KK-103 to reach affected joints and provide targeted pain relieve. First, the safety oftwo skin permeation enhancers, dimethyl sulfoxide (DMSO) and dimerized protamine (P2), will be determined. A range of formulations will then be tested in a laboratory model to measure theabsorption of KK-103 through the skin. Promising formulations will be further tested in a ratmodel of OA to assess their pain-relieving and anti-inflammatory effects. This project isexpected to yield a topical cream that will effectively relieve OA pain with minimal side effects.Combining KK-103 with advanced permeation techniques is a new approach that couldrevolutionize OA pain management. This localized treatment has the potential to provide a safer,more effective option for patients, contributing to an improved quality of life and reducedreliance on systemic drugs.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Oke, Benjamin T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~